Japanese drugmaker Kyowa Kirin is acquiring most of the commercial rights for Kura Oncology’s targeted leukemia treatment, paying $330 million upfront and almost $1.2 billion …
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
Haier Biomedical has launched a new generation of liquid nitrogen containers offering easy and convenient access to stored samples.
A novel curcumin derivative, C210, activates the Epstein–Barr virus (EBV) lytic cycle without producing infectious virions by disrupting HSP90. This discovery opens avenues for safer
What You Should Know: – HealthArc, a virtual healthcare company secures $5M in funding led by ScOp Venture Capital to transform healthcare through its advanced